AR091984A1 - Composicion oral solida que contiene colorantes para uso en diagnostico endoscopico - Google Patents

Composicion oral solida que contiene colorantes para uso en diagnostico endoscopico

Info

Publication number
AR091984A1
AR091984A1 ARP130103688A ARP130103688A AR091984A1 AR 091984 A1 AR091984 A1 AR 091984A1 AR P130103688 A ARP130103688 A AR P130103688A AR P130103688 A ARP130103688 A AR P130103688A AR 091984 A1 AR091984 A1 AR 091984A1
Authority
AR
Argentina
Prior art keywords
optionally
matrix
endoscopic diagnosis
composition containing
dye
Prior art date
Application number
ARP130103688A
Other languages
English (en)
Spanish (es)
Inventor
Moro Luigi
Repici Alessandro
Original Assignee
Cosmo Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cosmo Technologies Ltd filed Critical Cosmo Technologies Ltd
Publication of AR091984A1 publication Critical patent/AR091984A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/006—Biological staining of tissues in vivo, e.g. methylene blue or toluidine blue O administered in the buccal area to detect epithelial cancer cells, dyes used for delineating tissues during surgery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/003—Thiazine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A61K49/0076—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form dispersion, suspension, e.g. particles in a liquid, colloid, emulsion
    • A61K49/0084—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form dispersion, suspension, e.g. particles in a liquid, colloid, emulsion liposome, i.e. bilayered vesicular structure
    • A61K49/0086—Polymersome, i.e. liposome with polymerisable or polymerized bilayered-forming substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A61K49/0089—Particulate, powder, adsorbate, bead, sphere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Optics & Photonics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Physics & Mathematics (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ARP130103688A 2012-10-19 2013-10-10 Composicion oral solida que contiene colorantes para uso en diagnostico endoscopico AR091984A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261715981P 2012-10-19 2012-10-19
EP12189206.1A EP2722058A1 (en) 2012-10-19 2012-10-19 Solid oral composition containing dyes for use in endoscopic diagnosis

Publications (1)

Publication Number Publication Date
AR091984A1 true AR091984A1 (es) 2015-03-18

Family

ID=47137560

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP130103688A AR091984A1 (es) 2012-10-19 2013-10-10 Composicion oral solida que contiene colorantes para uso en diagnostico endoscopico

Country Status (27)

Country Link
US (4) US20150283268A1 (enExample)
EP (3) EP2722058A1 (enExample)
JP (1) JP6267210B2 (enExample)
KR (1) KR102207507B1 (enExample)
CN (3) CN112891563A (enExample)
AR (1) AR091984A1 (enExample)
AU (1) AU2013331964B2 (enExample)
BR (1) BR112015008772A2 (enExample)
CA (1) CA2886201C (enExample)
DK (2) DK2908866T3 (enExample)
ES (2) ES2721916T3 (enExample)
FI (1) FI3650048T3 (enExample)
HR (1) HRP20190710T1 (enExample)
HU (1) HUE043112T2 (enExample)
IL (1) IL237907A (enExample)
IN (1) IN2015DN02818A (enExample)
LT (1) LT2908866T (enExample)
MX (1) MX361737B (enExample)
NZ (1) NZ706363A (enExample)
PL (1) PL2908866T3 (enExample)
PT (1) PT2908866T (enExample)
RS (1) RS59152B1 (enExample)
RU (1) RU2649783C2 (enExample)
TR (1) TR201905800T4 (enExample)
TW (1) TWI651102B (enExample)
WO (1) WO2014060199A1 (enExample)
ZA (1) ZA201502370B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2019118459A (ru) * 2016-11-28 2020-12-28 Космо Текнолоджиз Лтд. Твердая пероральная композиция, содержащая красители
IT201900003113A1 (it) * 2019-03-04 2020-09-04 Azienda Ospedaliero Univ Policlinico S Orsola Malpighi Bologna Bevanda coadiuvante

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2129273C1 (ru) * 1997-11-26 1999-04-20 Московский научно-исследовательский онкологический институт им.П.А.Герцена Способ эндоскопической флюоресцентной диагностики злокачественных опухолей полых органов
WO2000076478A1 (en) 1999-06-14 2000-12-21 Cosmo S.P.A. Controlled release and taste masking oral pharmaceutical compositions
ITMI991316A1 (it) 1999-06-14 2000-12-14 Cip Ninety Two 92 S A Composizioni farmaceutiche orali a rilascio modificato di mesalazina
US7230088B2 (en) * 2001-07-03 2007-06-12 Mallinckrodt, Inc. Compounds for dual photodiagnosis and therapy
GB0224909D0 (en) * 2002-10-25 2002-12-04 Norgine Europe Bv Colon cleansing compositions
RU2253350C2 (ru) * 2003-06-30 2005-06-10 Государственное учреждение здравоохранения Иркутский Областной Диагностический Центр Способ эндоскопического исследования желудка
US20050244368A1 (en) * 2004-04-29 2005-11-03 Pashankar Dinesh S Pre-endoscopic use of polyethylene glycol compositions
FR2894253B1 (fr) * 2005-12-06 2009-11-13 Pentax Corp Composition d'histocolorant pour endoscope
IT1398643B1 (it) 2010-03-04 2013-03-08 Cosmo Technologies Ltd Composizione solida per la somministrazione orale di coloranti, e utilizzo diagnostico della stessa

Also Published As

Publication number Publication date
WO2014060199A1 (en) 2014-04-24
EP3650048A1 (en) 2020-05-13
EP2908866B1 (en) 2019-02-27
ES3030697T3 (en) 2025-07-01
ZA201502370B (en) 2016-11-30
IN2015DN02818A (enExample) 2015-09-11
HUE043112T2 (hu) 2019-08-28
JP6267210B2 (ja) 2018-01-24
MX361737B (es) 2018-12-14
EP2908866A1 (en) 2015-08-26
US20230130628A1 (en) 2023-04-27
CN104755107A (zh) 2015-07-01
CN117462704A (zh) 2024-01-30
TW201420131A (zh) 2014-06-01
BR112015008772A2 (pt) 2017-07-04
AU2013331964A1 (en) 2015-04-09
TR201905800T4 (tr) 2019-05-21
TWI651102B (zh) 2019-02-21
HK1211465A1 (en) 2016-05-27
DK3650048T3 (da) 2025-05-26
EP3650048B1 (en) 2025-03-05
IL237907A (en) 2017-06-29
RS59152B1 (sr) 2019-10-31
LT2908866T (lt) 2019-06-10
US20250186626A1 (en) 2025-06-12
NZ706363A (en) 2019-03-29
RU2015118584A (ru) 2016-12-10
MX2015004935A (es) 2015-12-01
JP2015534956A (ja) 2015-12-07
US20200129643A1 (en) 2020-04-30
US20150283268A1 (en) 2015-10-08
HRP20190710T1 (hr) 2019-08-23
KR20150068412A (ko) 2015-06-19
CN112891563A (zh) 2021-06-04
ES2721916T3 (es) 2019-08-06
DK2908866T3 (da) 2019-05-06
EP2722058A1 (en) 2014-04-23
AU2013331964B2 (en) 2018-03-29
CA2886201C (en) 2021-03-23
FI3650048T3 (fi) 2025-05-26
PT2908866T (pt) 2019-05-24
CA2886201A1 (en) 2014-04-24
PL2908866T3 (pl) 2019-10-31
RU2649783C2 (ru) 2018-04-04
KR102207507B1 (ko) 2021-01-27

Similar Documents

Publication Publication Date Title
ES2916649T1 (es) Composiciones y usos para el tratamiento de la esclerosis múltiple
GT200600096A (es) Composicion farmaceutica para el tratamiento del cancer
ECSP15039103A (es) Formulación de liberación sostenida de mosapride que proporciona efectos farmacológicos y clínicos con administración una vez al día
EA201590449A1 (ru) Перорально вводимая лекарственная композиция
BR112012021681A2 (pt) rifaximina em pó, processo para preparação da mesma e composições de liberação controladas contendo a referida rifaximina útil para obtenção de um efeito de longa duração.
MX2015009772A (es) Moduladores de receptores nmda de espiro-lactama y sus usos.
AR096892A1 (es) Una combinación farmacéutica para el tratamiento del melanoma
AR091233A1 (es) Composicion farmaceutica que comprende abediterol
CR20150628A (es) Derivados de la pirazolopirrolidina y su uso en el tratamiento de enfermedades
IL278188B1 (en) Sublingual formulation of riluzole
AR062659A1 (es) Composicion de liberacion sostenida de levodopa y metodo para su uso
AR073265A1 (es) Uso de dronedarona para la preparacion de un medicamento para la prevencion de ictus o ataque isquemico transitorio
CL2016001707A1 (es) Tratamiento de trastornos congnitivos con (r)-7-cloro-n-(quinuclidin-3-il) benzo(b)tiofeno-2-carboxamida y sales farmacéuticamente aceptables de la misma (div. sol. 1178-11).
EA201691034A1 (ru) Композиции в твердой форме с замедленным высвобождением для перорального введения
UA100883C2 (ru) Применение дронедарона для получения лекарственного средства для лечения пациентов с аритмией и с повышенным уровнем креатинина в результате введения дронедарона
AR080256A1 (es) Formulaciones farmaceuticas solidas de ramipril y besilato de amlodipino y su preparacion
CR20190203A (es) Composición farmacéutica con antagonista del receptor de mineralocorticoides y su uso
AR075866A1 (es) Una dosis de ave5026 para el tratamiento de tromboembolismo venoso en pacientes con deterioro renal severo. uso. composicion farmaceutica.
ES2721916T3 (es) Composición oral sólida que contiene colorantes para uso en diagnóstico endoscópico
BR112016009214A8 (pt) uso de um composto para preparação de um medicamento para o tratamento de distrofia muscular e composição farmacêutica
BR112015010651A2 (pt) composição antiparasitária de amplo espectro de nitazoxanida, probióticos e prebióticos
AR086491A1 (es) Composicion farmaceutica que comprende fexofenadina
ECSP12011627A (es) Otamixaban para el tratamiento de pacientes con alteración renal y de edad avanzada con infarto de miocardio sin elevación del st
BR112018014000A2 (pt) composição e método para tratar doença de chagas
EA201070175A1 (ru) Фармацевтическая композиция контролируемого высвобождения, содержащая толперизона гидрохлорид

Legal Events

Date Code Title Description
FC Refusal